269 related articles for article (PubMed ID: 25739032)
21. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
[TBL] [Abstract][Full Text] [Related]
22. Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Murata K; Sakamoto A
Int J Oncol; 2008 Dec; 33(6):1149-55. PubMed ID: 19020747
[TBL] [Abstract][Full Text] [Related]
23. Sequential fluctuation pattern of serum des-gamma-carboxy prothrombin levels detected by high-sensitive electrochemiluminescence system as an early predictive marker for hepatocellular carcinoma in patients with cirrhosis.
Shimizu A; Shiraki K; Ito T; Sugimoto K; Sakai T; Ohmori S; Murata K; Takase K; Tameda Y; Nakano T
Int J Mol Med; 2002 Mar; 9(3):245-50. PubMed ID: 11836630
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-induced des-gamma-carboxy prothrombin production in hepatocellular carcinoma.
Murata K; Suzuki H; Okano H; Oyamada T; Yasuda Y; Sakamoto A
Int J Oncol; 2010 Jan; 36(1):161-70. PubMed ID: 19956845
[TBL] [Abstract][Full Text] [Related]
25. Des-γ-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence.
Gao J; Feng X; Inagaki Y; Song P; Kokudo N; Hasegawa K; Sugawara Y; Tang W
Biosci Trends; 2012 Aug; 6(4):153-9. PubMed ID: 23006961
[TBL] [Abstract][Full Text] [Related]
26. The role of des-gamma-carboxy prothrombin levels in hepatocellular carcinoma and liver tissues.
Shimada M; Yamashita Y; Hamatsu T; Hasegawa H; Utsunomiya T; Aishima S; Sugimachi K
Cancer Lett; 2000 Oct; 159(1):87-94. PubMed ID: 10974410
[TBL] [Abstract][Full Text] [Related]
27. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
28. Analysis of serum α-fetoprotein-L3% and des-γ carboxyprothrombin markers in cases with misleading hepatocellular carcinoma total α-fetoprotein levels.
Hadziyannis E; Sialevris K; Georgiou A; Koskinas J
Oncol Rep; 2013 Feb; 29(2):835-9. PubMed ID: 23174906
[TBL] [Abstract][Full Text] [Related]
29. Roles and Signaling Pathways of Des-γ-Carboxyprothrombin in the Progression of Hepatocellular Carcinoma.
Cui SX; Yu XF; Qu XJ
Cancer Invest; 2016 Oct; 34(9):459-464. PubMed ID: 27673353
[TBL] [Abstract][Full Text] [Related]
30. Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: a preliminary report.
Toyoda H; Kumada T; Osaki Y; Tada T; Kaneoka Y; Maeda A
Cancer Sci; 2012 May; 103(5):921-5. PubMed ID: 22320249
[TBL] [Abstract][Full Text] [Related]
31. Des-γ-Carboxyprothrombin Plasma Level in Diagnosis of Hepatocellular Carcinoma in a Chinese Population Undergoing Surgery.
Feng X; Song P; Bie P; Jiang P; Ma K; Li X; Wang S; Wang Z; Tang W; Zheng S
Med Sci Monit; 2016 May; 22():1663-72. PubMed ID: 27187589
[TBL] [Abstract][Full Text] [Related]
32. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
Ma M; Qu XJ; Mu GY; Chen MH; Cheng YN; Kokudo N; Tang W; Cui SX
Chemotherapy; 2009; 55(1):28-35. PubMed ID: 18974646
[TBL] [Abstract][Full Text] [Related]
33. Serum des-gamma-carboxyprothrombin concentration determined by the avidin-biotin complex method in small hepatocellular carcinomas.
Saitoh S; Ikeda K; Koida I; Tsubota A; Arase Y; Chayama K; Kumada H
Cancer; 1994 Dec; 74(11):2918-23. PubMed ID: 7525036
[TBL] [Abstract][Full Text] [Related]
34. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity.
Okuda H; Nakanishi T; Takatsu K; Saito A; Hayashi N; Watanabe K; Magario N; Yokoo T; Naraki T
Cancer; 1999 Feb; 85(4):812-8. PubMed ID: 10091758
[TBL] [Abstract][Full Text] [Related]
35. Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma.
Shindoh J; Sugawara Y; Nagata R; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Tanaka T; Kokudo N
Transpl Int; 2014 Apr; 27(4):391-8. PubMed ID: 24472068
[TBL] [Abstract][Full Text] [Related]
36. Des-γ-carboxyprothrombin may be a promising biomarker to determine the therapeutic efficacy of sorafenib for hepatocellular carcinoma.
Ueshima K; Kudo M; Takita M; Nagai T; Tatsumi C; Ueda T; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Minami Y; Chung H; Sakurai T
Dig Dis; 2011; 29(3):321-5. PubMed ID: 21829024
[TBL] [Abstract][Full Text] [Related]
37. Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma.
Sugimoto H; Takeda S; Inoue S; Kaneko T; Watanabe K; Nakao A
Liver Int; 2003 Feb; 23(1):38-44. PubMed ID: 12640726
[TBL] [Abstract][Full Text] [Related]
38. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.
Marrero JA; Su GL; Wei W; Emick D; Conjeevaram HS; Fontana RJ; Lok AS
Hepatology; 2003 May; 37(5):1114-21. PubMed ID: 12717392
[TBL] [Abstract][Full Text] [Related]
39. Des-gamma-carboxy prothrombin and proliferative activity of hepatocellular carcinoma.
Suehiro T; Matsumata T; Itasaka H; Taketomi A; Yamamoto K; Sugimachi K
Surgery; 1995 Jun; 117(6):682-91. PubMed ID: 7539944
[TBL] [Abstract][Full Text] [Related]
40. Des-gamma-carboxy prothrombin (DCP) ratio is a useful prognostic tumor marker for single nodule hepatocellular carcinoma (HCC).
Murakami N; Tamano M; Yoneda M; Sugaya H; Hiraishi H
Hepatogastroenterology; 2008; 55(81):197-201. PubMed ID: 18507106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
